BBLGW (STOCKS)

    Bone Biologics Corp Warrants

    Change: —
    Prev close: —
    Company Information
    Exchange
    XNAS
    Sector
    Industry
    CEO
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    Employees
    2
    P/E (TTM)
    P/B (TTM)
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Dec 2025)
    Revenues $0.00
    Nonoperating Income/Loss $125.95K
    Operating Expenses $3.23M
    Research and Development $1.06M
    Other Operating Expenses $2.17M
    Operating Income/Loss -$3.23M
    Income/Loss From Continuing Operations After Tax -$3.10M
    Income/Loss From Continuing Operations Before Tax -$3.10M
    Net Income/Loss -$3.10M
    Net Income/Loss Attributable To Noncontrolling Interest $8.99K
    Net Income/Loss Attributable To Parent -$3.11M
    Net Income/Loss Available To Common Stockholders, Basic -$3.11M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$2.65
    Diluted Earnings Per Share -$2.65
    Basic Average Shares 1,174,869
    Diluted Average Shares 1,174,869
    Assets $5.80M
    Current Assets $5.80M
    Prepaid Expenses $10.00K
    Other Current Assets $5.79M
    Noncurrent Assets $0.00
    Liabilities $418.59K
    Current Liabilities $418.59K
    Noncurrent Liabilities $0.00
    Equity $5.38M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $5.38M
    Liabilities And Equity $5.80M
    Net Cash Flow From Operating Activities -$2.69M
    Net Cash Flow From Operating Activities, Continuing -$2.69M
    Net Cash Flow From Investing Activities -$2.01M
    Net Cash Flow From Investing Activities, Continuing -$2.01M
    Net Cash Flow From Financing Activities $4.70M
    Net Cash Flow From Financing Activities, Continuing $4.70M
    Net Cash Flow $0.00
    Net Cash Flow, Continuing $0.00
    Comprehensive Income/Loss -$3.10M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$3.10M
    Other Comprehensive Income/Loss $0.00